This site is a comprehensive resource for biotech enthusiasts, including investors, researchers, media, etc. You'll find information about drug discovery and development, the FDA approval process, and loads of links and information about specific drugs and biotech companies.
BiotechDueDiligence's Latest Posts
Genetics and decision-making in drug discovery Part 1: overview ANDDecision-making part 2: Genetics and assays for drug discoveryRobert Plenge (Plenge Lab blog)Biotech's recent examples of why turnover can be an ominous signBrad Loncar (Loncar blog) $ACRX $KINMaking clinical development more investable with “financially adaptive trials”Frank David (Pharmagellan)The Transformation: Is it possible to control cancer without killing it?Jerome Groopman (The New Yorker) […]
Please continue reading below for a new feature that we are excited to roll out here at BiotechDueDiligence. Conceived and curated by biotech trader @23aloha this blog series captures the tweets that best capture the biotech / pharma conversation on Twitter. The conversations here include reaction to and analysis of key market events and trends, as well as observations that in some cases go on to influence biotech stock trading. Feel free to offer any comments as we roll out this new effort! […]
How even a ridiculous, fake tweet can move stocks these daysBrad Loncar (Loncar Blog) $ICPTDIY Diagnosis: How an Extreme Athlete Uncovered Her Genetic FlawEd Yong (Pacific Standard)The Cancer Drug That Almost Wasn'tScience. $PFEAlso see companion write-up from In the Pipeline blog.The rise of the seemingly serious but “just for entertainment purposes” medical appBrian Dolan (Mobi Health News)Coke Confronts its Big Fat ProblemClaire Suddath and Duane Stanford (Bloomberg […]
Ebola OutbreakSpecial feature / homepage from the New England Journal of Medicine. You can also check out the FDA webpage dedicated to the Ebola crisis. $TKMR $SRPTMicrobiology: Microbiome science needs a healthy dose of skepticismWilliam Hanage. Nature.Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older AdultsDiazGranados et al. New England Journal of Medicine. $SNYDesign of Phase I Combination Trials: Recommendations of the Clinical Trial Design Task Force of the NCI […]
I am pleased to report that the Pipelines page has been completely updated over the past couple days. This feature highlights the latest links and files related to clinical research and development pipeline progress for major biotech and pharmaceutical companies. More and more, I am trying to host PDF files of the pipeline status rather than just a website link, in order to better preserve the historical context. I hope you find this resource useful and I welcome any feedback. […]
Log in to leave a comment